Hours before Ismail's death, a tube used to help patients breathe was found to be in the wrong position, the court heard.
Four people wearing protective clothing lowered Ismail's coffin into a grave at the Eternal Gardens Muslim Burial Ground
Ismail Mohamed Abdulwahab, 13, from Brixton, died of acute respiratory distress syndrome on 30 March 2020. Senior Coroner Andrew Harris said he would not have died when he did "were it not for the tube misplacement".Ismail Mohamed Abdulwahab died at King's College Hospital on 30 March 2020
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Breathing tube error 'may have contributed to UK's first child Covid death'An inquest has heard an issue with a breathing tube may have contributed to the death of the first child Covid victim in the UK.
Lire la suite »
Britain's first child victim of Covid died after breathing tube was misplacedBREAKING: Britain’s first child victim of Covid died after breathing tube was misplaced.
Lire la suite »
Misplaced breathing tube contributed to death of UK's first known child COVID victimA misplaced breathing tube contributed to the death of a 13-year-old boy who became the UK's first known child victim of COVID, a coroner has found.
Lire la suite »
Teenager saves Celtic fan's life when she stops breathing on way home from matchShannon Lorenston was heading to Queen Street Station after watching her team beat Motherwell 6-0 to win the title last May when she came across a woman who had collapsed.
Lire la suite »
Lucy Letby: Nurse denied dislodging baby's breathing tube, trial hearsLucy Letby is accused of 'interfering' with the baby's breathing tube two hours after her birth.
Lire la suite »
Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohortObjective To evaluate the effect of covid-19 vaccination on the severity of symptoms in patients with long covid. Design Target trial emulation based on ComPaRe e-cohort. Data source ComPaRe long covid cohort, a nationwide e-cohort (ie, a cohort where recruitment and follow-up are performed online) of patients with long covid, in France. Methods Adult patients (aged ≥18 years) enrolled in the ComPaRe cohort before 1 May 2021 were included in the study if they reported a confirmed or suspected SARS-CoV-2 infection, symptoms persistent for |3 weeks after onset, and at least one symptom attributable to long covid at baseline. Patients who received a first covid-19 vaccine injection were matched with an unvaccinated control group in a 1:1 ratio according to their propensity scores. Number of long covid symptoms, rate of complete remission of long covid, and proportion of patients reporting an unacceptable symptom state at 120 days were recorded. Results 910 patients were included in the analyses (455 in the vaccinated group and 455 in the control group). By 120 days, vaccination had reduced the number of long covid symptoms (mean 13.0 (standard deviation 9.4) in the vaccinated group v 14.8 (9.8) in the control group; mean difference −1.8, 95% confidence interval −3.0 to −0.5) and doubled the rate of patients in remission (16.6% v 7.5%, hazard ratio 1.93, 95% confidence interval 1.18 to 3.14). Vaccination reduced the effect of long covid on patients' lives (mean score on the impact tool 24.3 (standard deviation 16.7) v 27.6 (16.7); mean difference −3.3, 95% confidence interval −5.7 to −1.0) and the proportion of patients with an unacceptable symptom state (38.9% v 46.4%, risk difference −7.4%, 95% confidence interval −14.5% to −0.3%). In the vaccinated group, two (0.4%) patients reported serious adverse events requiring admission to hospital. Conclusion In this study, covid-19 vaccination reduced the severity of symptoms and the effect of long covid on patients' social,
Lire la suite »